News
Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions ...
Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...
If a routine streamlined a process and passed the common sense test, I was more than happy to adopt it. However, if it caused ...
Four Canadian nurses are among the 11 recipients of this year's International Nightingale Awards, which support innovative ...
Task-oriented training may help balance issues for people with MS, but current evidence is inconsistent, a study found.
Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.
Infections and stressful life events in childhood may increase the risk of developing MS, according to a study.
Body mass index (BMI) does not seem to affect responses to stem cell transplant in people with MS, a study found.
Ocrevus appears to be a safe and effective treatment for children and adolescents with MS, according to real-world data from ...
MS prevalence has increased by about one-third in New Zealand in recent decades, though some barriers to diagnosis still ...
Dr. Susan Payrovi and Dr. Mirla Avila have an in-depth discussion around treating MS, and considerations when selecting an MS treatment.
Columnist Desiree Lama explains the sometimes confusing experience of living with MS and anxiety that hits her every morning.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results